347 related articles for article (PubMed ID: 21668572)
1. Endoscopic ablative therapy for Barrett's esophagus: a potential cause of eosinophilic esophagitis.
Owens VL; Katzka DA; Lutzke LS; Wang KK; Smyrk TC
Dis Esophagus; 2012 Jan; 25(1):33-9. PubMed ID: 21668572
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of esophageal eosinophils in patients with Barrett's esophagus.
Ravi K; Katzka DA; Smyrk TC; Prasad GA; Romero Y; Francis DL; Lutzke L; Tian J; Wang KK
Am J Gastroenterol; 2011 May; 106(5):851-7. PubMed ID: 21304498
[TBL] [Abstract][Full Text] [Related]
3. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic infiltration of the esophagus following endoscopic ablation of Barrett's neoplasia.
Halsey KD; Arora M; Bulsiewicz WJ; Heath J; Petullo B; Madanick RD; Dellon ES; Shaheen NJ; Greenwald BD
Dis Esophagus; 2013; 26(2):113-6. PubMed ID: 22394268
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
6. Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia.
Sridhara S; Ravi K; Smyrk TC; Kita H; Kephart GM; Weiler CR; Katzka DA
Clin Gastroenterol Hepatol; 2012 Jul; 10(7):735-41. PubMed ID: 22289868
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
Yachimski P; Mino-Kenudson M; Sherwood ME; Puricelli WP; Nishioka NS; Lauwers GY
Virchows Arch; 2011 Dec; 459(6):581-6. PubMed ID: 22081106
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
9. Effects of Nissen fundoplication on endoscopic endoluminal radiofrequency ablation of Barrett's esophagus.
O'Connell K; Velanovich V
Surg Endosc; 2011 Mar; 25(3):830-4. PubMed ID: 20676687
[TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus.
Falk GW
Gastrointest Endosc Clin N Am; 1994 Oct; 4(4):773-89. PubMed ID: 7812646
[TBL] [Abstract][Full Text] [Related]
11. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
Sharma P; Sampliner RE; Camargo E
Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
[TBL] [Abstract][Full Text] [Related]
12. Multilayered epithelium may be found in patients with Barrett's epithelium and dysplasia or adenocarcinoma.
Upton MP; Nishioka NS; Ransil BJ; Rosenberg SJ; Puricelli WP; Zwas FR; Shields HM
Dig Dis Sci; 2006 Oct; 51(10):1783-90. PubMed ID: 16967312
[TBL] [Abstract][Full Text] [Related]
13. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
Yachimski P; Puricelli WP; Nishioka NS
Gastrointest Endosc; 2009 Feb; 69(2):205-12. PubMed ID: 18950764
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy for Barrett's esophagus: clinical update.
Overholt BF; Panjehpour M
Am J Gastroenterol; 1996 Sep; 91(9):1719-23. PubMed ID: 8792687
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy in Barrett's esophagus: reduction of specialized mucosa, ablation of dysplasia, and treatment of superficial esophageal cancer.
Overholt BF; Panjehpour M
Semin Surg Oncol; 1995; 11(5):372-6. PubMed ID: 7569560
[TBL] [Abstract][Full Text] [Related]
16. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
17. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
18. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma.
Weston AP; Sharma P
Am J Gastroenterol; 2002 Dec; 97(12):2998-3006. PubMed ID: 12492182
[TBL] [Abstract][Full Text] [Related]
19. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK
Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation is effective for the treatment of high-grade dysplasia in Barrett's esophagus after failed photodynamic therapy.
Dunn JM; Banks MR; Oukrif D; Mackenzie GD; Thorpe S; Rodriguez-Justo M; Winstanley A; Bown SG; Novelli MR; Lovat LB
Endoscopy; 2011 Jul; 43(7):627-30. PubMed ID: 21717379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
